Literature DB >> 661501

New cardiotonic agents: a search for digitalis substitute.

A E Farah, A A Alousi.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 661501     DOI: 10.1016/0024-3205(78)90083-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  16 in total

1.  Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs.

Authors:  A Dorszewski; B Müller-Beckmann; L Kling; G Sponer
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. Ireland, 6th-8th July, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

3.  Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence.

Authors:  P Honerjäger; M Schäfer-Korting; M Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

4.  Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents.

Authors:  C A Simonton
Journal:  West J Med       Date:  1985-02

5.  Evidence for two separated Ca2+ pathways in smooth muscle plasmalemma.

Authors:  K D Meisheri; O Hwang; C van Breemen
Journal:  J Membr Biol       Date:  1981-03-15       Impact factor: 1.843

Review 6.  Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.

Authors:  H von der Leyen
Journal:  Klin Wochenschr       Date:  1989-06-15

7.  Beneficial effect of amrinone on murine cardiac allograft survival.

Authors:  T Hirozane; A Matsumori; Y Furukawa; S Matsui; Y Sato; Y Matoba; S Sasayama
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

8.  Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes.

Authors:  J C Parker; J R Harper
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Effects of amrinone on the transmembrane action potential of rabbit sinus node pacemaker cells.

Authors:  I Kodama; N Kondo; S Shibata
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

Review 10.  Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.

Authors:  T A Fischer; R Erbel; N Treese
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.